Jesse J. Swen
Leiden University Medical Center(NL)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Pharmaceutical studies and practices, Colorectal Cancer Treatments and Studies, Renal Transplantation Outcomes and Treatments, Renal cell carcinoma treatment
Most-Cited Works
- → Pharmacogenetics: From Bench to Byte— An Update of Guidelines(2011)999 cited
- → Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update(2017)634 cited
- → Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group(2019)507 cited
- → A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study(2023)470 cited
- → Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants(2013)452 cited
- → Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process(2014)425 cited
- → DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis(2018)408 cited
- → Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing(2013)322 cited
- → Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines(2019)221 cited
- → Translating Pharmacogenomics: Challenges on the Road to the Clinic(2007)212 cited